对于紧急危及生命的静脉血栓栓塞的抗凝固治疗期间的他类药物:一篇评论
Carmine Siniscalchi1,2, Egidio Imbalzano3, Tiziana Meschi1
1Department of Medicine and Surgery, University of Parma, Via Antonio Gramsci 14, 43126 Parma, Italy.
Medicina (Kaunas, Lithuania)
|August 29, 2024
概括
虽然他类药物可以减少静脉血栓塞栓症 (VTE) 患者服用抗凝药的死亡和复发,但其在VTE预防和治疗中的作用仍在争论中. 需要进一步的研究来澄清它们的好处和风险.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 静脉血栓塞栓症 (VTE),包括肺栓塞 (PE) 和深静脉血栓症 (DVT),是一个主要的全球健康问题.
- 目前的VTE治疗方法,包括VKA和DOAC,存在出血风险,并且在预防复发方面存在局限性.
- 类药物在VTE中显示出潜在的保护作用,但关于它们在抗凝时的有效性和安全性存在相互矛盾的数据.
研究的目的:
- 审查目前关于他类药物在VTE预防和治疗中的作用的文献.
- 探索他类药物对VTE潜在影响的生物学机制.
- 评估他类药物对静脉瘤复发,死亡率和出血风险的影响.
主要方法:
- 对调查静脉瘤患者使用他类药物的研究的综合文献综述.
- 对生物机制的分析,包括对D-二次体,组织因子和凝结因子的影响.
- 对初级和二级VTE预防,出血风险和死亡率降低的数据的评估.
主要成果:
- 研究表明,在接受抗凝药治疗的患者中,他类药物可能会降低VTE复发和死亡率.
- 类药物会影响关键的静血因素,包括D-二聚体和组织因子表达.
- 存在相互矛盾的数据,而他类药物并不能替代已建立的VTE预防或治疗.
结论:
- 由于相互矛盾的证据,他类药物在VTE管理中的确切作用需要进一步调查.
- 在VTE的抗凝固过程中,他类药物可能提供生物保护功能.
- 目前的证据不支持将指南推的VTE疗法替换成他类药物.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...


